CoChat

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance

Open access
Herman, Rok, Sikonja, Jaka, Jensterle, Mojca, Janez, Andrej, Dolzan, Vita · 2023 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in women of reproductive age. Its heterogeneous clinical presentation is characterized by hyperandrogenemia, reproductive changes, polycystic ovary morphology, and insulin resistance (IR). The primary pathophysiological process in its multifactorial etiology has not yet been identified. However, the two most proposed core etiologies are the disruption of insulin metabolism and hyperandrogenemia, both of which begin to intertwine and propagate each other in the later stages of the disease. Insulin metabolism can be viewed as the interconnectedness of beta cell function, IR or insulin sensitivity, and insulin clearance. Previous studies of insulin metabolism in PCOS patients have yielded conflicting results, and literature reviews have focused mainly on the molecular mechanisms and clinical implications of IR. In this narrative review, we comprehensively explored the role of insulin secretion, clearance, and decreased sensitivity in target cells as a potential primary insult in PCOS pathogenesis, along with the molecular mechanism behind IR in PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms24043140

Cites

99 of 100 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Disrupted insulin metabolism resulting in hyperinsulinemia as an essential pathophysiological driver in PCOS development.
Figure 1 Disrupted insulin metabolism resulting in hyperinsulinemia as an essential pathophysiological driver in PCOS development.CC BY · PubMed Central
Figure 2 Insulin signaling pathway in PCOS. Unknown intracellular serine kinases may phosphorylate serine residues of insulin receptor and IRS, impairing the phosphorylation of tyrosine residues and signal transduction after stimulation with insulin. This renders the metabolic PI3K pathway defective, while the mitogenic MAPK pathway functions normally.
Figure 2 Insulin signaling pathway in PCOS. Unknown intracellular serine kinases may phosphorylate serine residues of insulin receptor and IRS, impairing the phosphorylation of tyrosine residues and signal transduction after stimulation with insulin. This renders the metabolic PI3K pathway defective, while the mitogenic MAPK pathway functions normally.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 100 references

Cited by

See all 69

Metadata

Authors
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V.
Affiliations
  • University of Ljubljana (SI)
  • Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia
  • Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2023-02-05
Volume
24
Issue
4
Pages
3140
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4319318242
Cited by
69
References
97
Citations by year
2026: 16 · 2025: 25 · 2024: 16 · 2023: 12
FWCI
2.80
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Slovenian Research Agency (ARRS) (P1-0170, P3-0298)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
polycystic ovary syndrome, insulin metabolism, insulin resistance, insulin secretion, insulin clearance, beta-cell function, hyperandrogenemia, insulin signaling, PCOS pathogenesis
MeSH terms
Female, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Signal Transduction, Hyperandrogenism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance. https://app.cochat.ai/papers/10.3390/ijms24043140
The paper
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023). Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.